Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suntech Pharmaceuticals

Explore full profile
Khagaria, IndiaBiotech & Life Sciences
Valuation $100–250M Last recorded · 2022
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Suntech Pharmaceuticals and the history behind them.

At a glance

Status
Operational
Headquarters
Khagaria, India
Open positions
None listed
Dealroom signal
23.3/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC May 2022 $28M $110M Shenzhen Guozhong Venture Capital Management · Anhui Chuanggu Capital · Guangdong Hengjian ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Teitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases Aarhus, Denmark Operational 25 $31M $123M
NeurOpResearch company developing different drug compounds Atlanta, United States Operational
Kringle PharmaKringle Pharma is a late clinical-stage biopharmaceutical company focused on research and development of regenerative medicines Toyonaka, Japan Operational
TAGCyx BiotechnologiesCreating candidate compounds for high-performance nucleic acid drugs with high affinity and specificity for target molecules using our proprietary nucleic acid basic technology Tokyo, Japan Acquired
Asgard TherapeuticsSpin-off company from Lund University focusing on developing cancer immunotherapies based on cell fate reprogramming Lund Municipality, Sweden Operational
AstronauTxSmall-molecule therapeutics targeting astrocytes for neurodegenerative diseases Reading, United Kingdom Operational
Integene InternationalPrivately held florida corporation Miami, United States Closed
ExonateTopical small-molecule therapeutics for retinal vascular diseases Cambridge, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • Shenzhen Guozhong Venture Capital Management
  • Anhui Chuanggu Capital
  • Guangdong Hengjian

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇳 India · Khagaria HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suntech Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suntech Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.